Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_assertion type Assertion NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_head.
- NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_assertion description "[The use of specific PDE inhibitors revealed that an increase in PDE1 and PDE3 activity largely accounted for reduced agonist-induced cAMP levels and increased proliferation in IPAH and SPH PASMC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_provenance.
- NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_assertion evidence source_evidence_literature NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_provenance.
- NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_assertion SIO_000772 16980375 NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_provenance.
- NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_assertion wasDerivedFrom befree-20150227 NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_provenance.
- NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_assertion wasGeneratedBy ECO_0000203 NP256796.RAB51oEu8ygNmCbcm-UGeje_2C0Vaf2-01WoSM93gULgs130_provenance.